These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1297 related items for PubMed ID: 7911399

  • 41. [Medico-economic aspects of the treatment of duodenal ulcer: from antisecretory treatment to eradication of Helicobacter pylori].
    Carrère MO, Auquier P, Poynard T, Sambuc R.
    Gastroenterol Clin Biol; 1995 Dec; 19(12):1023-30. PubMed ID: 8729415
    [Abstract] [Full Text] [Related]

  • 42. Rabeprazole: an update of its use in acid-related disorders.
    Carswell CI, Goa KL.
    Drugs; 2001 Dec; 61(15):2327-56. PubMed ID: 11772142
    [Abstract] [Full Text] [Related]

  • 43. Peptic ulcer therapy with lansoprazole and Helicobacter pylori eradication.
    Ogoshi K, Kato T, Sakagawa T.
    J Clin Gastroenterol; 1995 Dec; 20 Suppl 2():S97-9. PubMed ID: 7594354
    [Abstract] [Full Text] [Related]

  • 44. Drugs for treatment of peptic ulcers.
    Dajani EZ, Trotman BW.
    J Assoc Acad Minor Phys; 1992 Dec; 3(3):78-88. PubMed ID: 1353999
    [Abstract] [Full Text] [Related]

  • 45. Drug therapy of peptic ulcer disease.
    Ching CK, Lam SK.
    Br J Hosp Med; 1992 Dec; 54(2-3):101-6. PubMed ID: 7551483
    [Abstract] [Full Text] [Related]

  • 46. Clinical efficacy of lansoprazole in eradication of Helicobacter pylori.
    Katoh M, Asaka M, Kudoh M, Kagaya H, Katagiri M, Takeda H.
    J Clin Gastroenterol; 1995 Dec; 20 Suppl 2():S112-4. PubMed ID: 7594324
    [Abstract] [Full Text] [Related]

  • 47. Peptic ulcer recurrence during maintenance therapy with H2-receptor antagonist following first-line therapy with proton pump inhibitor.
    Kaneko E, Hoshihara Y, Sakaki N, Harasawa S, Ashida K, Asaka M, Asaki S, Nakamura T, Kobayashi K, Kajiyama G, Ogawa N, Yao T, Muto Y, Nakazawa S, Takemoto T.
    J Gastroenterol; 2000 Dec; 35(11):824-31. PubMed ID: 11085491
    [Abstract] [Full Text] [Related]

  • 48. [Activity of Lansoprazole (new proton pump inhibitor) against Helicobacter pylori and its therapeutic efficacy].
    Tamura K, Murai M, Tanaka M, Kawano S.
    Nihon Rinsho; 1993 Dec; 51(12):3261-6. PubMed ID: 8283644
    [Abstract] [Full Text] [Related]

  • 49. Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders.
    Barradell LB, Faulds D, McTavish D.
    Drugs; 1992 Aug; 44(2):225-50. PubMed ID: 1382017
    [Abstract] [Full Text] [Related]

  • 50. [Endoscopic stage classification of peptic ulcer and characterization of the healing process by proton pump inhibitors].
    Karasawa H, Miwa T.
    Nihon Rinsho; 1992 Jan; 50(1):74-80. PubMed ID: 1347333
    [Abstract] [Full Text] [Related]

  • 51. Lansoprazole. An update of its pharmacological properties and clinical efficacy in the management of acid-related disorders.
    Langtry HD, Wilde MI.
    Drugs; 1997 Sep; 54(3):473-500. PubMed ID: 9279507
    [Abstract] [Full Text] [Related]

  • 52. Rabeprazole: a review of its use in acid-related gastrointestinal disorders.
    Langtry HD, Markham A.
    Drugs; 1999 Oct; 58(4):725-42. PubMed ID: 10551440
    [Abstract] [Full Text] [Related]

  • 53. The therapeutic effect of proton pump inhibitors on Helicobacter pylori-positive gastric ulcers.
    Sasakii M, Joh T, Yokoyama Y, Seno K, Tsuchida K, Kurokawa T, Itoh M.
    J Pharm Pharmacol; 1999 Jul; 51(7):825-30. PubMed ID: 10467958
    [Abstract] [Full Text] [Related]

  • 54. [Recent studies on therapy of peptic ulcers].
    Asaka M.
    Nihon Naika Gakkai Zasshi; 1999 Sep 10; 88(9):1750-4. PubMed ID: 10581758
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Effects of lansoprazole plus amoxycillin on the cure of Helicobacter pylori infection in Japanese peptic ulcer patients.
    Kato M, Asaka M, Kudo M, Sukegawa M, Katagiri M, Koshiyama T, Kagaya H, Nishikawa K, Hokari K, Takeda H, Sugiyama T.
    Aliment Pharmacol Ther; 1996 Oct 10; 10(5):821-7. PubMed ID: 8899093
    [Abstract] [Full Text] [Related]

  • 59. [Proton pump inhibitors in the treatment of peptic ulcers resistant to H2-receptor antagonists].
    Asaka M, Kato M, Sato Y, Miyazaki T.
    Nihon Rinsho; 1992 Jan 10; 50(1):104-10. PubMed ID: 1347322
    [Abstract] [Full Text] [Related]

  • 60. Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group.
    Agrawal NM, Campbell DR, Safdi MA, Lukasik NL, Huang B, Haber MM.
    Arch Intern Med; 2000 May 22; 160(10):1455-61. PubMed ID: 10826458
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 65.